Notice2026-03084
Center for Scientific Review; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 17, 2026
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 31 (Tuesday, February 17, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 31 (Tuesday, February 17, 2026)]
[Notices]
[Page 7294]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-03084]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Drug and
Biologic Therapeutic Delivery Study Section, March 16, 2026, 09:00 a.m.
to March 17, 2026, 06:00 p.m., National Institutes of Health, Rockledge
II, 6701 Rockledge Drive, Bethesda, MD, 20892 which was published in
the Federal Register on February 11, 2026, 91 FR 6321, FRN Doc. 2026-
02669.
The meeting date changed from a 2-day meeting to a 1-day meeting,
March 16, 2026. The meeting is closed to the public.
Dated: February 12, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-03084 Filed 2-13-26; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on February 17, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.